Patents by Inventor David M. Hyman

David M. Hyman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MONITORING TREATMENT OF HISTIOCYTOSIS WITH VEMURAFENIB AND DABRAFENIB
    Publication number: 20150344957
    Abstract: Provided are methods of determining the amount of a BRAF V600E mutation over time in a subject with Langerhans Cell Histiocytosis (LCH) or Erdheim-Chester Disease (ECD) who is being treated with vemurafenib or dabrafenib.
    Type: Application
    Filed: May 30, 2015
    Publication date: December 3, 2015
    Inventors: Omar Abdel-Wahab, Elie L. Diamond, David M. Hyman, Filip Janku, Mark G. Erlander, Cecile Rose T. Vibat
  • DETECTING AND MONITORING MUTATIONS IN HISTIOCYTOSIS
    Publication number: 20150132256
    Abstract: Provided is methods of detecting a mutation in a histiocytosis patient. Also provided is methods of selecting and/or applying treatment or therapy for a histiocytosis patient. Further provided is a method of treating a patient having a histiocytosis.
    Type: Application
    Filed: October 18, 2014
    Publication date: May 14, 2015
    Inventors: Filip Janku, Mark G. Erlander, Cecile Rose Vibat, Karena Kosco, Abdel-Wahab Omar, Eli L. Diamond, David M. Hyman